Breast cancer drug

May 2005
CMAJ: Canadian Medical Association Journal;5/24/2005, Vol. 172 Issue 11, p1432
Academic Journal
Focuses on a new treatment option for Canadian women to reduce the threat of breast cancer beyond the 5 years of tamoxifen therapy. Basis of the approval given by Health Canada for letrozole for the treatment of hormone receptor-positive early breast cancer.


Related Articles

  • Differential effects of tamoxifen and anastrozole on optic cup size in breast cancer survivors. Julie Falardeau; John Samples; John Vetto // Breast Cancer Research & Treatment;Dec2007, Vol. 106 Issue 2, p161 

    Abstract Introduction  The main purpose of this study was to determine whether the optic cups of tamoxifen users and anastrozole users differ in size, with the cups of the tamoxifen users being smaller. Methods  Optic nerve head (ONH) topography was measured...

  • Tamoxifen: prevention is better than cure.  // PharmaWatch: Cancer;May 2003, Vol. 2 Issue 5, p21 

    Reports on the benefits of tamoxifen to women in the U.S. Growth in the market of the preventive drug; Use of the drug to prevent breast cancer; Approval of the drug as a chemopreventive agent in women.

  • Study Shows New Breast Cancer Drug Letrozole Shrinks Tumors More Effectively Than Tamoxifen.  // Ascribe Newswire: Medicine;12/10/2001, p18 

    A new cancer drug called letrozole (trade name Femara) worked better at shrinking breast cancer tumors than did the front-line breast cancer drug tamoxifen among a group of postmenopausal women with estrogen-positive tumors, according to a study coordinated by a Duke University Medical Center...

  • CANCER CARE: IS LESS MORE? Song, Sora // Time International (South Pacific Edition);9/13/2004, Issue 36, p67 

    The article presents information on a study that shows that breast cancer grows slowly in older women. In the study, the research was conducted on the breast-cancer survivors whose small tumors had been treated with lumpectomy and tamoxifen. In about 8% of women aged more than 50 years, cancer...

  • Tamoxifen for women at high risk of breast cancer. Nazarali, Safia A.; Narod, Steven A. // Breast Cancer: Targets & Therapy;2014, Vol. 6, p29 

    Tamoxifen has been used as a treatment for women who have been diagnosed with breast cancer for roughly four decades and has been approved as chemoprevention for over ten years. Although tamoxifen has been proven to be beneficial in preventing breast cancer in high-risk women, its use has not...

  • Breast cancer: Tamoxifen benefits node-positive elders after mastectomy.  // Geriatrics;Aug1991, Vol. 46 Issue 8, p17 

    This article presents a study, conducted by Frank Cummings and colleagues, who analyzed findings in 168 older women with node-positive breast cancer who were treated for 2 years following mastectomy with either tamoxifen, 20 mg/d, or placebo. Of 102 deaths in this series, 61% were due to breast...

  • Endometrial Cancer Risk After Tamoxifen Therapy. Walling, Anne D. // American Family Physician;3/15/2001, Vol. 63 Issue 6, p1204 

    Presents a study by L. Bergman and others that assessed the relationship between tamoxifen therapy and the risk of endometrial cancer. Description of the study and its results; Conclusion that the survival benefits of tamoxifen in the treatment of women with breast cancer far outweigh the...

  • Anastrozole in breast cancer.  // Practice Nurse;8/18/2006, Vol. 32 Issue 3, p16 

    The article discusses research being done on the effectiveness of anastrozole in breast cancer. It references a study published in a 2006 issue of Lancet Oncology. Researchers say that anastrozole is better tolerated than tamoxifen in early breast cancer and is associated with a lower recurrence...

  • Anti-Estrogen Therapy May Reduce Lung Cancer Mortality.  // Pulmonary Reviews;Feb2011, Vol. 16 Issue 2, p6 

    The article discusses the results of a study which confirms the efficacy of anti-breast cancer drug, Tamoxifen in reducing lung cancer risk and death in women.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics